Chemotherapy-induced cardiotoxicity and mitigation
Moving in Circulation, Blood and Nature Communications.
- Moved, week to 23 Oct 2026
- 0
- Papers in 60 days
- 4
Add Chemotherapy-induced cardiotoxicity and mitigation as an interest in JClubFree on iPhone and Android · interests shape Home, Discover and your digest
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Chemotherapy-induced cardiotoxicity and mitigation
Newest first · last 60 days
IFN-γ-driven inflammation causes long-term bone marrow niche dysfunction after doxorubicin chemotherapy, impairing hematopoietic and skeletal health.
- Open access
- 1 cites
ICI-associated myocarditis is part of a systemic cardiomuscular syndrome with variable severity, affecting up to 50% of cases and requiring tailored management strategies.
Add Chemotherapy-induced cardiotoxicity and mitigation as an interest in JClub
Browse JClub
Journals this month
- bioRxiv6192
- medRxiv1716
- PNAS472
- Sci Adv398
- JAMA274
- Environ Res230
- BMJ200
- Nat Commun171
- Environ Pollution165
- Nature161
- NEJM146
- Science141
- Lancet132
- Cell Rep130
- Curr Biol108
- J Exp Bot108
- mBio107
- Plant Cell Environ107
Topics moving, week to 23 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Bacteriophages and microbial interactions5
- Gut microbiota and health5
- Genomics and Phylogenetic Studies4
- Cancer Genomics and Diagnostics4
- Cancer Immunotherapy and Biomarkers4
- Alzheimer's disease research and treatments3
- Inflammatory Bowel Disease3
- Influenza Virus Research Studies3